Supplier-induced demand in healthcare raises serious ethical questions. Analyse the role of incentives, regulation and medical education in curbing overmedication.

Supplier-induced demand (SID) occurs when providers, who know far more than patients, create demand for tests and drugs the patient does not need. In India it shows up as unwarranted check-up tests and irrational antibiotic use. Curbing it needs incentives, regulation and education working together.

Ethical questions raised

• Non-maleficence: unwarranted tests in routine health-check packages cause false positives, anxiety, overdiagnosis and overtreatment [1].
• Conflict of interest: "economic incentives from pharmaceutical companies" are a documented driver of irrational prescribing [2].
• Justice: needless spending raises out-of-pocket costs, and antibiotic misuse feeds AMR, which harms future patients.

Role of incentives

• Perverse pricing: the reserve antibiotic gemifloxacin costs less than first-line drugs, which encourages its misuse [2]. Prices should follow the order in which drugs ought to be used.
• Weak penalty for suppliers: in the first UCPMP case, AbbVie got only a reprimand for sponsoring doctors' foreign trips [4].
• System pressures: heavy OPD loads and fear of losing patients push doctors to prescribe defensively [2]. More primary-care staff would ease this.

Role of regulation

• UCPMP 2024 (12 March 2024) bars gifts, cash and hospitality to doctors and their families, replacing the voluntary 2014 code [3].
• Gap: it is a departmental code, not a statute. In October 2026 the Supreme Court directed the Centre to set up a committee on statutory regulation of pharma marketing [5].
• Last mile: over-the-counter (OTC) antibiotic sales are a focus of national AMR policy, but enforcement is spotty, and trained pharmacists are scarce in rural areas [6].

Role of medical education

• The lack of continuing medical education (CME) keeps outdated prescribing habits alive [2]. Mandatory, industry-free CME on rational prescribing is needed.
• Risk-based screening: doctors should be trained to match tests to the patient's risk, not to fixed packages [1].
• Stewardship culture: prescription audits and state plans such as Delhi's SAP-CARD can turn training into practice [2].

Overmedication is therefore a systemic failure: perverse incentives, soft regulation and outdated training reinforce one another. A statutory marketing law, rational drug pricing and mandatory CME can restore patient trust. The goal is appropriate care, not simply less care, in line with the right to health under Article 21 and SDG 3.